FDA Media Alert Detail

Drug Shortage

FDA Drug Shortage: Epinephrine Bitartrate, Lidocaine Hydrochloride Injection

  • U.S. Food and Drug Administration
  • August 24, 2026
  • ID: shortage-epinephrine-bitartrate-lidocaine-hydrochloride-injection-hospira-inc-a-pfizer-company-0409-3181-01

Drug Shortage Details

Generic NameEpinephrine Bitartrate, Lidocaine Hydrochloride Injection
Manufacturer / CompanyHospira, Inc., a Pfizer Company
Therapeutic CategoryAnesthesia, Pediatric
Availability StatusAvailable
Status (FDA list)Current
NDC Package Code0409-3181-01
Presentation & Dosage Form

Lidocaine Hydrochloride And Epinephrine, Injection, 450 mg/30 mL (1.5%; 1:200,000) (NDC 0409-3181-01)

Manufacturer Contact Info

844-646-4398


Content syndicated from the U.S. Food and Drug Administration (FDA) Drug Shortages Database.